Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer
Titel:
Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer
Auteur:
Diamond, Jennifer R. Becerra, Carlos Richards, Donald Mita, Alain Osborne, Cynthia O’Shaughnessy, Joyce Zhang, Chun Henner, Randall Kapoun, Ann M. Xu, Lu Stagg, Bob Uttamsingh, Shailaja Brachmann, Rainer K. Farooki, Azeez Mita, Monica